Although C/EBPβ function is described at both promoters and enhancers23,42, our findings implicate enhancers as the principal sites at which C/EBPβ/BRD4 complexes target to regulate gene activation in HCC cells. Here, BRD4 is linked to hepatocellular carcinoma.